Seeking Alpha

The FDA approves Kyprolis to treat patients with multiple myeloma who have received at least two...

The FDA approves Kyprolis to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade and an immunomodulatory therapy. Shares of Onyx (ONXX) remain halted.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|